NIFEDIAC CC Trademark

Trademark Overview

On Tuesday, October 29, 2002, a trademark application was filed for NIFEDIAC CC with the United States Patent and Trademark Office. The USPTO has given the NIFEDIAC CC trademark a serial number of 78179655. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 29, 2016. This trademark is owned by TEVA Pharmaceuticals USA, Inc.. The NIFEDIAC CC trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cardiovascular disease; calcium channel blockers

General Information

Serial Number78179655
Word MarkNIFEDIAC CC
Filing DateTuesday, October 29, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 29, 2016
Registration Number3000589
Registration DateTuesday, September 27, 2005
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 5, 2005

Trademark Statements

Disclaimer with Predetermined TextCC
Goods and Servicespharmaceutical preparations for the treatment of cardiovascular disease; calcium channel blockers

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 29, 2016
Primary Code005
First Use Anywhere DateTuesday, December 30, 2003
First Use In Commerce DateTuesday, December 30, 2003

Trademark Owner History

Party NameTEVA PHARMACEUTICALS CURACAO N.V.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCURACAO
AN
Party NameTEVA Pharmaceuticals USA, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 194541090
Party NameTEVA Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 194541090
Party NameTEVA Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 194541090

Trademark Events

Event DateEvent Description
Friday, April 29, 2016CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, September 29, 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, September 29, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, September 26, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 30, 2011TEAS SECTION 8 & 15 RECEIVED
Wednesday, December 1, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 1, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 5, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 5, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 10, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 10, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 25, 2009AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 27, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, July 5, 2005PUBLISHED FOR OPPOSITION
Wednesday, June 15, 2005NOTICE OF PUBLICATION
Thursday, March 31, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 25, 2005ASSIGNED TO LIE
Tuesday, March 22, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 18, 2005AMENDMENT FROM APPLICANT ENTERED
Thursday, March 3, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 3, 2005PAPER RECEIVED
Friday, January 21, 2005REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, July 6, 2004LETTER OF SUSPENSION MAILED
Tuesday, July 6, 2004USE AMENDMENT ACCEPTED
Monday, June 21, 2004AMENDMENT FROM APPLICANT ENTERED
Monday, June 21, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 2, 2004AMENDMENT TO USE PROCESSING COMPLETE
Monday, June 21, 2004USE AMENDMENT FILED
Monday, June 21, 2004PAPER RECEIVED
Wednesday, April 16, 2003LETTER OF SUSPENSION MAILED
Tuesday, April 8, 2003ASSIGNED TO EXAMINER
Thursday, January 9, 2003PAPER RECEIVED

Related Keywords

nifediac calcium channel blockers disease cardiovascular preparations treatment pharmaceutical